Hospital
ST Francis Hospital
ST Francis Hospital was paid $14.37M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoST FRANCIS HOSPITAL
ESCANABA, MI 49829
ESCANABA, MI 49829
33aNPI1922058551assigned 05/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.37M
24GClaims497,985
24DCodes billed245
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#55 of 86
Median peer was paid$21.55M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SEHRING, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,299 | $932K | |
| 2019 | 72,694 | $1.31M | |
| 2020 | 71,332 | $2.01M | |
| 2021 | 84,120 | $2.78M | |
| 2022 | 82,826 | $2.55M | |
| 2023 | 81,636 | $2.62M | |
| 2024incomplete | 57,078 | $2.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 11,036 | 10,183 | $2.84M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 5,700 | 5,276 | $2.31M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 9,993 | 9,365 | $1.54M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.1% | 3,131 | 2,896 | $592K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 4,843 | 3,910 | $560K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 4,555 | 4,339 | $452K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 11,863 | 3,554 | $401K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 5,214 | 5,056 | $353K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 2,698 | 2,474 | $298K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 2,394 | 1,791 | $282K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 1,798 | 1,641 | $259K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 4,586 | 3,800 | $215K |
233 more codes
| 71045 | Radiologic examination, chest; single view | 1.5% | 3,944 | $210K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 5,310 | $172K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 3,646 | $164K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 456 | $153K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,355 | $140K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,075 | $126K |
| 76830 | Ultrasound, transvaginal | <1% | 1,792 | $125K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,721 | $119K |
| 97161 | <1% | 1,866 | $117K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 6,727 | $114K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,935 | $112K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,509 | $108K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,134 | $99K |
| 80053 | Comprehensive metabolic panel | <1% | 29,295 | $85K |
| 76857 | <1% | 1,084 | $84K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,481 | $77K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,329 | $77K |
| 86900 | <1% | 2,195 | $72K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 43,234 | $70K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,027 | $70K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 988 | $68K |
| 80061 | Lipid panel | <1% | 5,954 | $66K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 459 | $62K |
| 76801 | <1% | 836 | $61K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 418 | $61K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,848 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 30,970 | $59K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,811 | $58K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,844 | $57K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 114 | $54K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 359 | $51K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,298 | $48K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 915 | $47K |
| 73630 | <1% | 1,848 | $44K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 317 | $44K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 180 | $39K |
| 86780 | <1% | 3,715 | $38K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 51 | $36K |
| 73610 | <1% | 1,388 | $35K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 1,840 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,752 | $32K |
| 73130 | <1% | 1,332 | $32K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,934 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,222 | $28K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 193 | $28K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 361 | $27K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 584 | $26K |
| 95811 | <1% | 42 | $26K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,220 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,029 | $24K |
| 73564 | <1% | 449 | $23K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 377 | $23K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 521 | $23K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,708 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,424 | $22K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 436 | $22K |
| 73030 | <1% | 865 | $21K | |
| 73110 | <1% | 715 | $21K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,112 | $20K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 25 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,736 | $18K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 237 | $18K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 56 | $17K |
| 72100 | <1% | 480 | $17K | |
| 84702 | <1% | 2,153 | $15K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 24 | $14K |
| 93976 | <1% | 215 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 696 | $13K |
| 82728 | <1% | 1,628 | $12K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 457 | $12K |
| 81025 | <1% | 8,372 | $11K | |
| 73562 | <1% | 579 | $11K | |
| 87186 | <1% | 2,811 | $11K | |
| 82607 | <1% | 1,226 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,917 | $11K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 435 | $10K |
| 76641 | <1% | 161 | $9K | |
| 84439 | <1% | 1,855 | $9K | |
| 85027 | <1% | 2,472 | $9K | |
| 93971 | <1% | 152 | $8K | |
| 87102 | <1% | 1,652 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,094 | $8K |
| 94060 | <1% | 42 | $8K | |
| 87428 | <1% | 391 | $8K | |
| 87070 | <1% | 1,528 | $6K | |
| 70496 | <1% | 25 | $6K | |
| 87088 | <1% | 1,691 | $6K | |
| 74018 | <1% | 323 | $6K | |
| 83735 | <1% | 9,236 | $5K | |
| 71271 | <1% | 67 | $5K | |
| 73502 | <1% | 161 | $5K | |
| 81002 | <1% | 2,291 | $5K | |
| 86850 | <1% | 4,278 | $5K | |
| 85610 | <1% | 4,886 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 31 | $5K |
| 83880 | <1% | 2,673 | $5K | |
| 87340 | <1% | 1,555 | $5K | |
| 87205 | <1% | 1,935 | $4K | |
| 87077 | <1% | 1,072 | $4K | |
| 86803 | <1% | 911 | $4K | |
| 93225 | <1% | 53 | $4K | |
| 82570 | <1% | 1,334 | $4K | |
| 86140 | <1% | 2,841 | $4K | |
| 87147 | <1% | 872 | $4K | |
| 87210 | <1% | 1,046 | $4K | |
| 81001 | <1% | 8,366 | $3K | |
| 59025 | Fetal non-stress test | <1% | 40 | $3K |
| 81003 | <1% | 6,549 | $3K | |
| 82746 | <1% | 393 | $3K | |
| 84144 | <1% | 214 | $3K | |
| 82950 | <1% | 861 | $3K | |
| 82043 | <1% | 710 | $3K | |
| 87081 | <1% | 692 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,580 | $3K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $2K |
| 74019 | <1% | 114 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 108 | $2K |
| 83690 | <1% | 4,485 | $2K | |
| 80074 | <1% | 91 | $2K | |
| 83001 | <1% | 145 | $2K | |
| 87807 | <1% | 444 | $2K | |
| 71250 | <1% | 24 | $2K | |
| 82962 | <1% | 2,786 | $2K | |
| 70486 | <1% | 42 | $2K | |
| 82565 | <1% | 704 | $2K | |
| 85652 | <1% | 1,772 | $2K | |
| 84146 | <1% | 117 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 35 | $2K |
| 87184 | <1% | 436 | $1K | |
| 83540 | <1% | 362 | $1K | |
| 87522 | Neg quan hep c or qual rna | <1% | 38 | $1K |
| 85379 | <1% | 2,201 | $1K | |
| 94726 | <1% | 79 | $1K | |
| 36592 | <1% | 1,192 | $889.95 | |
| 84481 | <1% | 120 | $873.50 | |
| 82550 | <1% | 1,065 | $862.27 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72 | $844.48 |
| 82150 | <1% | 1,192 | $819.40 | |
| 84403 | <1% | 42 | $800.10 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,215 | $728.71 |
| 87040 | <1% | 2,827 | $631.31 | |
| 84466 | <1% | 80 | $610.63 | |
| 85730 | <1% | 1,358 | $598.00 | |
| 84484 | <1% | 5,232 | $577.26 | |
| 86762 | <1% | 481 | $529.33 | |
| 71101 | <1% | 30 | $453.39 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 36 | $448.98 |
| 86787 | <1% | 434 | $421.53 | |
| 86769 | <1% | 12 | $336.48 | |
| 74022 | <1% | 58 | $335.64 | |
| 83605 | <1% | 3,428 | $313.03 | |
| 82077 | <1% | 1,835 | $311.77 | |
| 82670 | <1% | 14 | $265.20 | |
| 80076 | <1% | 54 | $261.60 | |
| 83655 | <1% | 28 | $252.79 | |
| 86308 | <1% | 126 | $250.49 | |
| 86038 | <1% | 43 | $230.58 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,335 | $217.30 |
| 73080 | <1% | 14 | $212.44 | |
| 93017 | <1% | 12 | $211.17 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,706 | $198.35 |
| 80179 | <1% | 1,130 | $192.27 | |
| 73590 | <1% | 17 | $181.85 | |
| 82248 | <1% | 56 | $181.45 | |
| 80143 | <1% | 1,144 | $177.28 | |
| 83002 | <1% | 13 | $164.04 | |
| 84145 | <1% | 461 | $152.51 | |
| 70498 | <1% | 12 | $144.30 | |
| 82785 | <1% | 13 | $143.22 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 13 | $138.28 |
| 82803 | <1% | 453 | $74.84 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 739 | $71.82 |
| 82247 | <1% | 21 | $69.66 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,935 | $48.72 |
| 82274 | <1% | 12 | $44.80 | |
| 88304 | <1% | 25 | $25.85 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,045 | $18.53 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,020 | $16.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,658 | $15.86 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,121 | $12.42 |
| 86901 | <1% | 2,362 | $12.36 | |
| 84703 | <1% | 12 | $7.77 | |
| 85018 | <1% | 15 | $7.48 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 82 | $6.90 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,675 | $5.12 |
| 83615 | <1% | 13 | $4.86 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 416 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 4,315 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,593 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 931 | $0.00 |
| 96376 | 0% | 574 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 131 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 269 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 1,147 | $0.00 |
| 12001 | 0% | 12 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,449 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 584 | $0.00 |
| 80349 | 0% | 349 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 389 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 29 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 202 | $0.00 |
| 36416 | 0% | 70 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 12 | $0.00 |
| J3490 | Unclassified drugs | 0% | 68 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 12 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 49 | $0.00 |
| 0099U | 0% | 15 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 55 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 16 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 44 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 20 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 16 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,889 | $0.00 |
| 80348 | 0% | 1,063 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 315 | $0.00 |
| 99001 | 0% | 40 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 1,106 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 427 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 1,383 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,485 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 2,251 | $0.00 |
| 93226 | 0% | 54 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 44 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 51 | $0.00 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 254 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 51 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 12 | $0.00 |
| 94729 | 0% | 78 | $0.00 | |
| 88312 | 0% | 91 | $0.00 | |
| 90715 | 0% | 56 | $0.00 | |
| 82009 | 0% | 13 | $0.00 | |
| 99152 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSEHRING, ROBERT (CEO, OSF HEALTHCARE SYSTEM)
Parent organizationOSF HEALTHCARE SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Osf Healthcare System | Peoria, IL | $16.78M |
| Saint Francis Medical Center | Peoria, IL | $11.26M |
| ST Francis Hospital | Escanaba, MI | $7.92M |
| Saint Francis Medical Center | Peoria, IL | $7.30M |
| Saint Anthony Medical Center | Loves Park, IL | $6.62M |
| ST Mary Medical Center | Galesburg, IL | $5.10M |
| Osf Healthcare System | Monmouth, IL | $4.94M |
| ST Joseph Medical Center | Bloomington, IL | $4.76M |
| Ottawa Regional Hospital & Healthcare Center | Ottawa, IL | $1.96M |
| Saint Anthony Medical Center | Rockford, IL | $1.95M |
| ST Joseph Medical Center | Bloomington, IL | $1.94M |
| Osf Healthcare System | Rockford, IL | $1.45M |
| Osf Healthcare System | Monmouth, IL | $1.12M |
| ST Francis Hospital | Gladstone, MI | $969K |
| ST Mary Medical Center | Galesburg, IL | $931K |
| Saint James Hospital | Pontiac, IL | $688K |
| Saint Anthony Medical Center | Rockford, IL | $420K |
| Saint Francis Medical Center | Peoria, IL | $374K |
| Osf Healthcare System | Oak Lawn, IL | $368K |
| Mendota Community Hospital | Mendota, IL | $359K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.